JACQUELINE QI: Open Payments
NPI 1215539556 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 15 payments from 10 companies in 2025. Trend: 2023 $159 · 2024 $663 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $91 |
| ABBVIE INC. | 3 | $85 |
| Incyte Corporation | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
| LNHC, Inc | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Davol Inc. | 1 | $17 |
| Organon LLC | 1 | $13 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, ZELSUVMI, RINVOQ, LIBTAYO, CIBINQO, Phasix Mesh.
Industry payments across CA — which companies pay providers there.
